Chronic Spontaneous Urticaria Triggered by the AstraZeneca/Oxford COVID-19 Vaccine with Achieved Remission: A Case Report.

Stephanie G BrooksAnna M De JongMina AbbaslouGordon Sussman

Published in: Allergy & rhinology (Providence, R.I.) (2022)

New adverse reactions to the COVID-19 vaccines are being identified as vaccination rates increase worldwide. Recently, there have been two reports of Moderna (mRNA-1273) vaccine induced relapse of chronic spontaneous urticaria (CSU) that was previously well controlled. Herein, we report a case of AstraZeneca/Oxford (ChAdOx1) vaccine triggered CSU in a patient with no history of CSU with achieved remission.

Keyphrases

coronavirus disease
sars cov
drug induced
disease activity
high glucose
adverse drug
ulcerative colitis
diabetic rats
rheumatoid arthritis
emergency department
binding protein